Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase UNSPECIFIED ION MODE | R1 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 | Peak area |
Reversed phase UNSPECIFIED ION MODE | R2 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 | Peak area |
Reversed phase UNSPECIFIED ION MODE | R3 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 | Peak area |
Reversed phase UNSPECIFIED ION MODE | R4 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 | Peak area |
Reversed phase UNSPECIFIED ION MODE | R5 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 | Peak area |
Reversed phase UNSPECIFIED ION MODE | R6 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 | Peak area |
Reversed phase UNSPECIFIED ION MODE | N1 | Source:Healthy Control Liver Tissue | Peak area |
Reversed phase UNSPECIFIED ION MODE | N2 | Source:Healthy Control Liver Tissue | Peak area |
Reversed phase UNSPECIFIED ION MODE | N3 | Source:Healthy Control Liver Tissue | Peak area |
Reversed phase UNSPECIFIED ION MODE | F1 | Source:NASH Liver Tissue from Patient | Peak area |
Reversed phase UNSPECIFIED ION MODE | F2 | Source:NASH Liver Tissue from Patient | Peak area |
Reversed phase UNSPECIFIED ION MODE | F3 | Source:NASH Liver Tissue from Patient | Peak area |